즉 훵색약징속편 훵색의 약물이 임상적 중요도에 있어서 훵색약징 훵색에 수재된 약물과 큰 차이가 없는 것으로 생각된다.
In other words, it is considered that there is no significant difference in clinical importance between the drugs listed in the short-term contract and the drugs listed in the sub-drug.